Literature DB >> 17105816

Generation of peripheral B cells occurs via two spatially and temporally distinct pathways.

Robert Coleman Lindsley1, Matthew Thomas, Bhaskar Srivastava, David Allman.   

Abstract

We have identified a population of newly formed bone marrow (BM) B cells that shares multiple characteristics with late transitional B cells in the spleen. Both late splenic transitional B cells and cells within this uncharacterized BM population expressed the cell-surface phenotype AA4(+) CD23(+), yet the developmental kinetics and the renewal rate of AA4(+) CD23(+) BM B cells mirrored recently formed BM B cells. Further, unlike the least mature B cells in the BM and spleen, AA4(+) CD23(+) BM B cells expressed the homing receptor CD62L, were dependent on the antiapoptotic cytokine receptor BR3 and the tec family kinase Btk, and proliferated in response to IL-4 plus CD40 stimulation. Finally, frequencies of lambda light chain-positive B cells declined among AA4(+) CD23(+) B cells in both the BM and spleen, suggesting that V-gene selection events correlate with CD23 expression in both compartments. These observations indicate that the first step in B-cell maturation occurs in both the BM and the periphery and suggest that recently formed B cells exit the BM as a heterogeneous pool of immature and semimature B cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105816     DOI: 10.1182/blood-2006-04-018085

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  54 in total

Review 1.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

2.  Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigen.

Authors:  Bao Hoa Duong; Takayuki Ota; Djemel Aït-Azzouzene; Miyo Aoki-Ota; José Luis Vela; Christoph Huber; Kevin Walsh; Amanda L Gavin; David Nemazee
Journal:  J Immunol       Date:  2010-03-15       Impact factor: 5.422

Review 3.  Characterization of splenic CD21hi T2 B cells.

Authors:  Shilpi Verma; Thomas J Waldschmidt
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 4.  Phenotypic and functional heterogeneity of human memory B cells.

Authors:  Iñaki Sanz; Chungwen Wei; F Eun-Hyung Lee; Jennifer Anolik
Journal:  Semin Immunol       Date:  2008-02-06       Impact factor: 11.130

5.  GM-CSF and IL-4 Fusion Cytokine Induces B Cell-Dependent Hematopoietic Regeneration.

Authors:  Jiusheng Deng; Yanqiu Li; Andrea Pennati; Shala Yuan; Jian Hui Wu; Edmund K Waller; Jacques Galipeau
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454

Review 6.  Peripheral B cell subsets.

Authors:  David Allman; Shiv Pillai
Journal:  Curr Opin Immunol       Date:  2008-04-21       Impact factor: 7.486

Review 7.  The follicular versus marginal zone B lymphocyte cell fate decision.

Authors:  Shiv Pillai; Annaiah Cariappa
Journal:  Nat Rev Immunol       Date:  2009-11       Impact factor: 53.106

8.  S1P1 receptor directs the release of immature B cells from bone marrow into blood.

Authors:  Maria L Allende; Galina Tuymetova; Bridgin G Lee; Eliana Bonifacino; Yun-Ping Wu; Richard L Proia
Journal:  J Exp Med       Date:  2010-04-19       Impact factor: 14.307

9.  A novel Rac-dependent checkpoint in B cell development controls entry into the splenic white pulp and cell survival.

Authors:  Robert B Henderson; Katarzyna Grys; Anne Vehlow; Carine de Bettignies; Agnieszka Zachacz; Tom Henley; Martin Turner; Facundo Batista; Victor L J Tybulewicz
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

10.  Development of immunoglobulin lambda-chain-positive B cells, but not editing of immunoglobulin kappa-chain, depends on NF-kappaB signals.

Authors:  Emmanuel Derudder; Emily J Cadera; J Christoph Vahl; Jing Wang; Casey J Fox; Shan Zha; Geert van Loo; Manolis Pasparakis; Mark S Schlissel; Marc Schmidt-Supprian; Klaus Rajewsky
Journal:  Nat Immunol       Date:  2009-05-03       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.